"FDA Chief Warns of Deadly Scam: Fake Weight Loss Drugs Flood Online Market"

FDA Commissioner Dr. Robert Califf has raised concerns about the sale of fake weight loss drugs online, particularly compounded and counterfeit versions of GLP-1 agonist drugs like Ozempic and Mounjaro, which are approved for treating type 2 diabetes and obesity. The drugs, in high demand due to their weight loss effects, have experienced shortages, leading some users to seek alternatives online. The FDA has issued warning letters to online vendors for selling illicit versions of these drugs, emphasizing the risks of consuming unregulated and potentially harmful medications.